Exploring the latest in GVHD management through clinical case discussions and focusing on MCL cases

Hematology-Live > Malignant > Lymphoma
Exploring the latest in GVHD management through clinical case discussions and focusing on MCL cases
17
Jul
Biosimilars: Concept and Misconceptions, Journey from Concept to Reality, and Their Role as Value-Based Biologics.
17
Jul
Unmet Needs & Treatment Evolution in 3L+ DLBCL: Focus on T-Cell Engagers and Practical Considerations in Bi-specifics
17
Jul
Management & Treatment of MCL
14
Jun
DLBCL Management
08
Jun
DLBCL: The Role of Biosimilar Rituximab
26
Mar

Speaker: Dr. Khalil Al Farsi Affiliations: Senior Consultant in the Hematology/BMT Department, Sultan Qaboos University Hospital, Muscat, Oman   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.

Antibody Therapies for Diffuse Large B Cell Lymphoma: What does the Future Hold?
26
Mar

Speaker: Dr. Faraz Khan Affiliations: Chairman of Virtual Education Emirates Society of Hematology, Oncologist/Hematologist at American Hospital, United Arab Emirates.   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.

Biosimilar Concept & Rixathon Clinical Trial
26
Mar

Speaker: Dr. Amar Lal Affiliations: Consultant Hematologist, Tawam Hospital, Al Ain, United Arab Emirates   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.

Relapsed Diffuse Large Cell Lymphoma
26
Mar

Speaker: Dr. Arif Alam Affiliations: Division Chief of Hematology Clinic, Tawam Hospital, United Arab Emirates   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.

New Approaches to First-Line Management in Follicular Lymphoma
26
Mar

Speaker: Dr. Andrew Davies Affiliations: Director, Southampton Experimental Cancer Medicine Center, United Kingdom   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.

eaccme

Accreditation Statement

The Hematology Live Online Education, made available on https://hematologylive.online/ and organized by Meeting Minds Experts, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.

 

Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMSEACCME website have formally been accredited.

 

Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.